Literature DB >> 15491751

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

John So1, Jason Navari, Feng-Qiang Wang, David A Fishman.   

Abstract

OBJECTIVE: We previously reported that lysophosphatidic acid (LPA) stimulates cellular invasion of ovarian cancer (OVCA) cells by enhancing membrane-type-1-matrix metalloproteinase (MT1-MMP)-mediated activation of MMP2. Here, we investigate a second mechanism in which LPA enhances cellular invasion through the increased expression of IL-8, independent of the expression or activation of MMP2.
METHODS: Epithelial ovarian carcinoma cells (DOV 13) were exposed to LPA (80 microM) and IL-8 (100 ng/ml) for 24 h. IL-8 expression was quantified by enzyme-linked immunosorbent assay (ELISA). Cellular invasion (Matrigel invasion), migration (colloidal gold), and urinary-type plasminogen activator (uPA) activity (colorimetric assay) were quantified. Conditioned medium was also assayed for MMP activation and expression by SDS-PAGE gelatin zymography, ELISA, and Western blotting. In addition, IL-8 neutralizing antibody and MMP inhibitors were employed.
RESULTS: Our results found LPA to increase IL-8 expression threefold. IL-8 did not affect cellular migration, MMP2 activation, or uPA expression. However, exposure to various concentrations of IL-8 increased cellular invasiveness. Using an IL-8 blocking antibody and various MMP inhibitors, we determined that the increase in invasion was IL-8-dependent, while independent of the activation of MMP2 or MMP9. We further determined IL-8 exposure increased the expression of matrilysin (MMP7). Cells exposed to LPA and IL-8 resulted in a synergistic effect on cellular invasion. Adding the IL-8 blocking antibody, slightly decreased cellular invasion, indicating LPA in part, increases cellular invasion through the increased expression of IL-8.
CONCLUSION: We have identified a separate mechanism of enhanced cellular invasion, which is independent of MMP2 activation and involves the increased expression of IL-8 and subsequent increased expression of MMP7.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491751     DOI: 10.1016/j.ygyno.2004.08.001

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.

Authors:  Xiaohui Zhang; Pengfei Li; Junying Bao; Santo V Nicosia; Honggang Wang; Steven A Enkemann; Wenlong Bai
Journal:  J Biol Chem       Date:  2005-08-10       Impact factor: 5.157

2.  Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.

Authors:  Lídia Hernandez; Sarah C Hsu; Ben Davidson; Michael J Birrer; Elise C Kohn; Christina M Annunziata
Journal:  Cancer Res       Date:  2010-04-27       Impact factor: 12.701

3.  Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.

Authors:  Sang Hun Shin; Jaeyoon Kim; Soon Chul Heo; Yang Woo Kwon; Young Mi Kim; In-San Kim; Taehoon G Lee; Jae Ho Kim
Journal:  Mol Cell Proteomics       Date:  2011-12-07       Impact factor: 5.911

4.  CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases.

Authors:  Jiyuan Sun
Journal:  World J Biol Chem       Date:  2010-12-26

5.  Interleukin-8 promotes human ovarian cancer cell migration by epithelial-mesenchymal transition induction in vitro.

Authors:  J Yin; F Zeng; N Wu; K Kang; Z Yang; H Yang
Journal:  Clin Transl Oncol       Date:  2014-11-06       Impact factor: 3.405

6.  Lysophosphatidic acid (LPA)—a perspective marker in ovarian cancer.

Authors:  Iva Sedláková; Jaroslava Vávrová; Jindřich Tošner; Ladislav Hanousek
Journal:  Tumour Biol       Date:  2011-04

Review 7.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 8.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

9.  S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.

Authors:  Kathleen M Devine; Yoel Smicun; Joanie Mayer Hope; David A Fishman
Journal:  Gynecol Oncol       Date:  2008-05-29       Impact factor: 5.482

Review 10.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.